BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tombetti E, Mason JC. Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology 2019;58:206-19. [DOI: 10.1093/rheumatology/key040] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Abe N, Kono M, Kono M, Katsuyama T, Ohmura K, Sato T, Karino K, Fujieda Y, Kato M, Hasebe R, Murakami M, Atsumi T. Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel vasculitis: A preliminary observational study. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1066916] [Reference Citation Analysis]
2 Yuqing M, Shang G, Qing G, Jiyang W, Ruihao L, Zuoguan C, Yongpeng D, Zhiyuan W, Yongjun L. Transcriptome profiling of abdominal aortic tissues reveals alterations in mRNAs of Takayasu arteritis. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1036233] [Reference Citation Analysis]
3 Wang Y, Ma L, Sun Y, Yu W, Wu S, Chen H, Dai X, Ma L, Jiang L. Risk factors of aortic regurgitation progression in Chinese patients with Takayasu's arteritis: a prospective cohort study. Ther Adv Chronic Dis 2022;13:20406223221127237. [PMID: 36213170 DOI: 10.1177/20406223221127237] [Reference Citation Analysis]
4 Iba Ba J, Ayo Bivigou E, Allognon C, Akagha C, Beyeme Beyeme OU, Soto Lores LF, Boguikouma JB. [Takayasu's disease: an underdiagnosed entity in Sub-Saharan Africa. Report of five Gabonese cases]. Med Trop Sante Int 2022;2:mtsi. [PMID: 36284554 DOI: 10.48327/mtsi.v2i3.2022.272] [Reference Citation Analysis]
5 Danda D, Manikuppam P, Tian X, Harigai M. Advances in Takayasu arteritis: An Asia Pacific perspective. Front Med 2022;9. [DOI: 10.3389/fmed.2022.952972] [Reference Citation Analysis]
6 Takaishi K, Takata M, Aoki R, Fujiwara SJL, Kawahito S, Kitahata H. Total Intravenous Anesthesia Using Remimazolam and Continuous Cardiac Output Monitoring for Dental Anesthesia in a Patient With Takayasu’s Arteritis: A Case Report. A&A Practice 2022;16:e01599. [DOI: 10.1213/xaa.0000000000001599] [Reference Citation Analysis]
7 Dai X, Wang J, Zhang X, Wang L, Wu S, Chen H, Sun Y, Ma L, Ma L, Kong X, Jiang L. Biomarker Changes and Molecular Signatures Associated with Takayasu Arteritis Following Treatment with Glucocorticoids and Tofacitinib. JIR 2022;Volume 15:4395-407. [DOI: 10.2147/jir.s369963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Svensson C, Bjarnegård N, Eriksson P, Jonasson H, Strömberg T, Sjöwall C, Zachrisson H. Affected Microcirculation and Vascular Hemodynamics in Takayasu Arteritis. Front Physiol 2022;13:926940. [DOI: 10.3389/fphys.2022.926940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kermani TA, Warrington KJ, Dua AB. Treatment Guidelines in Vasculitis. Rheumatic Disease Clinics of North America 2022. [DOI: 10.1016/j.rdc.2022.03.006] [Reference Citation Analysis]
10 Lo Gullo A, Giuffrida C, Morace C, Squadrito G, Magnano San Lio P, Ricciardi L, Salvarani C, Mandraffino G. Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review. Front Med 2022;9:824630. [DOI: 10.3389/fmed.2022.824630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Aeschlimann FA, Yeung RSM, Laxer RM. An Update on Childhood-Onset Takayasu Arteritis. Front Pediatr 2022;10:872313. [DOI: 10.3389/fped.2022.872313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, Grayson PC, McAdoo SP, Mason JC, Owen C, Weyand CM, Youngstein T, Dhaun N. Large-vessel vasculitis. Nat Rev Dis Primers 2022;7:93. [PMID: 34992251 DOI: 10.1038/s41572-021-00327-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
13 Biradar S, Umakanth A. Takayasu arteritis in young female a case report. APIK J Int Med 2022;10:124. [DOI: 10.4103/ajim.ajim_88_20] [Reference Citation Analysis]
14 Ahn SS, Han M, Park YB, Jung I, Lee SW. Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea. Stroke Vasc Neurol 2021:svn-2020-000809. [PMID: 34880114 DOI: 10.1136/svn-2020-000809] [Reference Citation Analysis]
15 Oura K, Yamaguchi Oura M, Itabashi R, Maeda T. Vascular Imaging Techniques to Diagnose and Monitor Patients with Takayasu Arteritis: A Review of the Literature. Diagnostics (Basel) 2021;11:1993. [PMID: 34829340 DOI: 10.3390/diagnostics11111993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang H, Zhao L, Zhang C, Tian J, Ding Y, Zhao X, Ma X. Quantification of Myocardial Deformation in Patients with Takayasu Arteritis by Cardiovascular Magnetic Resonance Feature Tracking Imaging. J Magn Reson Imaging 2021. [PMID: 34582063 DOI: 10.1002/jmri.27942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Nakaoka Y, Yanagawa M, Hata A, Yamashita K, Okada N, Yamakido S, Hayashi H, Jayne D. Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial. Rheumatology (Oxford) 2021:keab684. [PMID: 34528074 DOI: 10.1093/rheumatology/keab684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ren YL, Li TT, Cui W, Zhao LM, Gao N, Liao H, Zhang JH, Zhu JM, Qiao ZY, Guo SC, Pan LL. CD8+ T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis. Sci Rep 2021;11:17111. [PMID: 34429489 DOI: 10.1038/s41598-021-96632-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kong X, Sun Y, Dai X, Wang L, Ji Z, Chen H, Jin X, Ma L, Jiang L. Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study. Ann Rheum Dis 2021:annrheumdis-2021-220832. [PMID: 34362744 DOI: 10.1136/annrheumdis-2021-220832] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
20 Jia S, Liu L, Ma J, Chen X. Application progress of multiple imaging modalities in Takayasu arteritis. Int J Cardiovasc Imaging 2021. [PMID: 34287748 DOI: 10.1007/s10554-021-02348-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ma LY, Wu B, Jin XJ, Sun Y, Kong XF, Ji ZF, Chen RY, Cui XM, Shi HC, Jiang LD. A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study. Rheumatology (Oxford) 2021:keab487. [PMID: 34156465 DOI: 10.1093/rheumatology/keab487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Porter A, Youngstein T, Babar S, Mason JC. A rare life-threatening presentation of Takayasu arteritis. Rheumatology (Oxford) 2021;60:iii6-8. [PMID: 34137876 DOI: 10.1093/rheumatology/keab036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kondo M, Murakawa Y, Kaneko S, Iwahashi T, Honda M, Moriyama M. Takayasu arteritis developing during the course of palmoplantar pustulosis. Int J Rheum Dis 2021;24:970-2. [PMID: 34137172 DOI: 10.1111/1756-185X.14161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Montúfar-Robles I, Soto ME, Jiménez-Morales S, Gamboa R, Huesca-Gómez C, Ramírez-Bello J. Polymorphisms in TNFAIP3, but not in STAT4, BANK1, BLK, and TNFSF4, are associated with susceptibility to Takayasu arteritis. Cell Immunol 2021;365:104375. [PMID: 33975174 DOI: 10.1016/j.cellimm.2021.104375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Keleşoğlu Dinçer AB, Kılıç L, Erden A, Kalyoncu U, Hazirolan T, Kiraz S, KaradaĞ Ö. Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis. Turk J Med Sci 2021;51:224-30. [PMID: 33155792 DOI: 10.3906/sag-2005-70] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Tombetti E, Hysa E, Mason JC, Cimmino MA, Camellino D. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides. Curr Rheumatol Rep 2021;23:17. [PMID: 33569633 DOI: 10.1007/s11926-021-00980-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
27 Aizawa Y, Miki K, Fujii S, Iwase R, Fujita K, Sawada K, Saigusa K, Maehara T, Nemoto S, Sumita K. Endovascular Percutaneous Transluminal Angioplasty and Mechanical Thrombectomy in a Patient with Takayasu's Arteritis and Acute Cerebral Infarction : A Case Report. Jpn J Neurosurg 2021;30:139-145. [DOI: 10.7887/jcns.30.139] [Reference Citation Analysis]
28 Cherednichenko Y, Dzyak L, Tsurkalenko O. The experience of comprehensive conservative and endovascular management of Takayasu arteritis, manifested with repeated ischemic strokes. Interdisciplinary Neurosurgery 2020;22:100789. [DOI: 10.1016/j.inat.2020.100789] [Reference Citation Analysis]
29 Dammacco F, Cirulli A, Simeone A, Leone P, Pulli R, Angiletta D, Rubini G, Di Palo A, Vacca A, Dammacco R. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances. Clin Exp Med 2021;21:49-62. [PMID: 33026580 DOI: 10.1007/s10238-020-00668-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
30 Porter A, Mason JC. Intervention in Takayasu Aortitis: When, Where and How? Hearts 2020;1:62-74. [DOI: 10.3390/hearts1020008] [Reference Citation Analysis]
31 Ren Y, Du J, Guo X, Liu O, Liu W, Qi G, Pan L. Cardiac valvular involvement of Takayasu arteritis. Clin Rheumatol 2021;40:653-60. [PMID: 32666179 DOI: 10.1007/s10067-020-05290-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tombetti E, Mulè A, Tamanini S, Matteucci L, Negro E, Brucato A, Carnovale C. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020. Curr Cardiol Rep 2020;22:59. [PMID: 32562029 DOI: 10.1007/s11886-020-01308-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
33 Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, Polimeni A, de Vincentiis M. Pathophysiology and therapy of systemic vasculitides. EXCLI J 2020;19:817-54. [PMID: 32665772 DOI: 10.17179/excli2020-1512] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
34 Li T, Du J, Gao N, Guo X, Pan L. Numano type V Takayasu arteritis patients are more prone to have coronary artery involvement. Clin Rheumatol 2020;39:3439-47. [DOI: 10.1007/s10067-020-05123-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Porter A, Youngstein T, Tombetti E, Mason JC. Biologic therapy in supra-aortic Takayasu arteritis can improve symptoms of cerebral ischaemia without surgical intervention. Rheumatology (Oxford) 2020;59:iii28-32. [PMID: 32348517 DOI: 10.1093/rheumatology/kez616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Fuertes-Martín R, Correig X, Vallvé JC, Amigó N. Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment. J Clin Med 2020;9:E354. [PMID: 32012794 DOI: 10.3390/jcm9020354] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
37 Shek Y, Song SS. Takayasu’s Arteritis. Carotid Artery Disease 2020. [DOI: 10.1007/978-3-030-41138-1_16] [Reference Citation Analysis]
38 Alizadehasl A, Saedi S, Ganji H, Pourafkari L. Isolated peripheral pulmonary stenosis in Takayasu arteritis. Int J Rheum Dis 2019;23:116-9. [DOI: 10.1111/1756-185x.13742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tombetti E, Giani T, Brucato A, Cimaz R. Recurrent Pericarditis in Children and Adolescents. Front Pediatr 2019;7:419. [PMID: 31681717 DOI: 10.3389/fped.2019.00419] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
40 Tomiyama R, Hokama A, Koga E, Shimabukuro K, Oishi Y, Ohira T, Iraha A, Kinjo T, Fujita J. Stroke and neck bruit in a boy with Crohn's disease. Intest Res 2019;17:565-6. [PMID: 30974933 DOI: 10.5217/ir.2019.00019] [Reference Citation Analysis]
41 Fragoulis GE, Evangelatos G, Iliopoulos A. Takayasu arteritis: "bitten apple" in the aorta, odd finding in a plain X-ray. Clin Rheumatol 2019;38:3307-8. [PMID: 31372854 DOI: 10.1007/s10067-019-04711-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Akiyama M, Kaneko Y, Takeuchi T. Does microbiome contribute to HLA-B52-positive Takayasu arteritis? Modern Rheumatology 2020;30:213-7. [DOI: 10.1080/14397595.2019.1584146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Banerjee S, Quinn KA, Gribbons KB, Rosenblum JS, Civelek AC, Novakovich E, Merkel PA, Ahlman MA, Grayson PC. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis. J Rheumatol 2020;47:99-107. [PMID: 30877209 DOI: 10.3899/jrheum.181222] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
44 Podgorska D, Podgorski R, Aebisher D, Dabrowski P. Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment. J Appl Biomed 2019;17:20. [PMID: 34907753 DOI: 10.32725/jab.2018.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Becker MO, Maurer B, Distler O. Formen der Vaskulitis. Gefässchirurgie 2019;24:104-113. [DOI: 10.1007/s00772-018-0499-0] [Reference Citation Analysis]
46 Azhar H, Rizvi SAH, Siddiqui AA, Siddiqui FQ. Back Pain: A Rare Presentation of Takayasu Arteritis. Cureus 2019;11:e4028. [PMID: 31007986 DOI: 10.7759/cureus.4028] [Reference Citation Analysis]
47 Tombetti E, Godi C, Ambrosi A, Doyle F, Jacobs A, Kiprianos AP, Youngstein T, Bechman K, Manfredi AA, Ariff B, Mason JC. Novel Angiographic Scores for evaluation of Large Vessel Vasculitis. Sci Rep 2018;8:15979. [PMID: 30374116 DOI: 10.1038/s41598-018-34395-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
48 Akamine K, Punaro M. Biologics for childhood systemic vasculitis. Pediatr Nephrol 2019;34:2295-309. [PMID: 30203375 DOI: 10.1007/s00467-018-4076-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
49 Mason JC. Surgical intervention and its role in Takayasu arteritis. Best Pract Res Clin Rheumatol 2018;32:112-24. [PMID: 30526891 DOI: 10.1016/j.berh.2018.07.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]